Butalbital, Acetaminophen, And Caffeine
NDC Package 33358-059-60
Package Information
Butalbital, Acetaminophen, And Caffeine is butalbital, acetaminophen, and caffeine tablets, USP are indicated for the relief of the symptom complex of tension (or muscle contraction) headache.Evidence supporting the efficacy and safety of this combination product in the treatment of multiple recurrent headaches is unavailable. Marketed by Rxchange Co., this product is identified by NDC 33358-059 and is authorized under FDA application ANDA200243.
Identification & Billing
- RxCUI: 238154 - butalbital 50 MG / acetaminophen 325 MG / caffeine 40 MG Oral Tablet
- RxCUI: 238154 - acetaminophen 325 MG / butalbital 50 MG / caffeine 40 MG Oral Tablet
- RxCUI: 238154 - APAP 325 MG / butalbital 50 MG / caffeine 40 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 33358 - Rxchange Co.
- 33358-059 - Butalbital, Acetaminophen, And Caffeine
- 33358-059-60 - 60 TABLET in 1 BOTTLE, PLASTIC
- 33358-059 - Butalbital, Acetaminophen, And Caffeine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (33358-059). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 33358-059-60 identifies a specific commercial package of 60 tablet in 1 bottle, plastic of Butalbital, Acetaminophen, And Caffeine, labeled by Rxchange Co.. This product is billed for "EA" each discreet unit and contains an estimated amount of 60 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Rxchange Co. on November 06, 2014. The current certification is valid through December 31, 2018.
How is this Rxchange Co. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 33358005960. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.